  |
 | Up a level |
Neal, Bruce and Perkovic, Vlado and Mahaffey, Kenneth W. and de Zeeuw, Dick and Fulcher, Greg and Erondu, Ngozi and Shaw, Wayne and Law, Gordon and Desai, Mehul and Matthews, David R. and Ukraine, : and Larin, Oleksandr and Panina, Svetlana and Kovalenko, Svitlana and Voloshyna, Olena and Tseluyko, Vera and Gyrina, Olga and Vizir, Vadim and Barna, Olga and Dolzhenko, Maryna and Mostovoy, Yuriy and Korpachev, Vadim and Mankovskiy, Boris and Vatutin, Mykola (2017) Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. The New England Journal of Medicine = N Engl J Med, 377 (7). pp. 644-657. ISSN 0028-4793 (print); 1533-4406 (online)
Fulcher, G. and Matthews, D.R. and Perkovic, V. and de Zeeuw, D. and Mahaffey, K.W. and Mathieu, C. and Woo, V. and Wysham, C. and Capuano, G. and Desai, M. and Shaw, W. and Vercruysse, F. and Meininger, G. and Neal, B. and CANVAS trial collaborative group and Ukraine: and Larin, Oleksandr and Panina, Svetlana and Popik, Galyna and Kovalenko, Svitlana and Voloshyna, Olena and Tseluyko, Vera and Gyrina, Olga and Vizir, Vadim and Barna, Olga and Dolzhenko, Maryna and Ignatenko, Grigoriy and Mostovoy, Yuriy and Korpachev, Vadim and Mankovskiy, Boris and Vatutin, Mykola (2016) Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes. Diabetes, Obesity and Metabolism, 18 (1). pp. 82-91. ISSN 1462-8902 (Print), 1463-1326 (Online)
